Sherbrooke Park Advisers’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,353	Closed	-$369K	–	779
2024 Q4	$369K	Sell	2,353 -26	-1%	-$4.07K	0.12%	316
2024 Q3	$433K	Buy	2,379 +1,044	+78%	+$190K	0.1%	368
2024 Q2	$245K	Sell	1,335 -2,996	-69%	-$550K	0.04%	703
2024 Q1	$771K	Buy	+4,331	New	+$771K	0.15%	220